Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RYCFX vs. BBH: which is better?

Bottom line

RYCFX vs BBH: the short answer

RYCFX (Biotechnology Fund) and BBH (VanEck Biotech ETF) are both mutual funds.

But RYCFX is far broader, holding 74 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.

BBH is cheaper at 0.35% vs 2.38% — a difference of $203 a year per $10,000 invested.

Over five years, RYCFX returned +3.0% a year vs +2.7% for BBH.

Updated Nov 19, 2026

RYCFX vs BBH side by side

RYCFXBBH
TypeMutual fundETF
Fund familyGuggenheimVanEck
CategoryTechnology SectorTechnology Sector
Expense ratio2.38%0.35%
Annual cost per $10k$238$35
10-yr cost on $10k (prospectus)$2,763$443
Max front load0%None
12b-1 fee1%—
1-yr return+28.4%+21.2%
5-yr return (annualized)+3.0%+2.7%
10-yr return (annualized)+4.8%+4.5%
Best quarter+28.0%+27.6%
Worst quarter−22.7%−18.2%
Net assets (fund)$136.8M$395.6M
Number of holdings7425
Portfolio turnover75%19%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRYCFXBBHDifference
2025+29.4%+21.2%+8.3%
2024−1.7%−4.4%+2.7%
2023+5.0%+3.9%+1.1%
2022−13.9%−15.1%+1.2%
2021+0.8%+11.8%−11.0%
2020+20.9%+22.1%−1.2%
2019+23.8%+25.8%−2.0%
2018−9.9%−10.2%+0.3%
2017+28.4%+16.6%+11.8%
2016−20.3%−15.0%−5.3%

Source: Fund prospectus bar charts

Holdings overlap

16 of RYCFX's top 25 holdings also appear in BBH's top 25.

Shared top holdings
HoldingRYCFXBBH
Amgen Inc5.05%15.25%
Gilead Sciences Inc4.49%12.79%
Vertex Pharmaceuticals Inc4.32%9.10%
Regeneron Pharmaceuticals Inc2.93%6.21%
Revolution Medicines Inc2.48%5.27%
Alnylam Pharmaceuticals Inc2.36%3.83%
Beone Medicines Ltd2.17%2.81%
Moderna Inc2.15%3.36%
Biogen Inc2.13%3.63%
Natera Inc2.12%4.92%
Illumina Inc1.94%3.17%
Insmed Inc1.79%2.67%
United Therapeutics Corp1.72%2.83%
Incyte Corp1.62%2.49%
Neurocrine Biosciences Inc1.52%2.08%

Source: SEC Form N-PORT

RYCFX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

FAQ

What is the difference between RYCFX and BBH?
RYCFX (Biotechnology Fund) and BBH (VanEck Biotech ETF) are both mutual funds. But RYCFX is far broader, holding 74 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
Which is cheaper, RYCFX or BBH?
BBH has the lower expense ratio (0.35%).
Should I own both RYCFX and BBH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.